APA (7th ed.) Citation
(2026). Senolytic Treatment With Fisetin Reverses Age‐Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12. Aging Cell.
Chicago Style (17th ed.) Citation
"Senolytic Treatment With Fisetin Reverses Age‐Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12." Aging Cell 2026.
MLA (9th ed.) Citation
"Senolytic Treatment With Fisetin Reverses Age‐Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12." Aging Cell, 2026.
Warning: These citations may not always be 100% accurate.